Oxurion NV Information

Oxurion is a Euronext Brussels-listed holding company focused on building a next-generation European platform dedicated to clinical data, biometrics and AI-driven clinical research services. Through a targeted buy-and-build strategy, Oxurion aims to consolidate high-value CRO and clinical technology capabilities across Europe Platform Highlights - 72% controlling stake in (Axiodis CRO), a French specialist in clinical biometrics and data management - Proprietary Next-Gen eCRF & Data Management System: Exagis - 7,000+ patient files processed across 12+ countries - 20+ active academic, biotech and pharmaceutical partners Expertise spanning biometrics, data management, statistical analysis and regulatory-ready clinical data - AI integration roadmap including intelligent data validation and virtual patient technologies - Active acquisition strategy targeting complementary CRO and clinical data businesses across Europe - Scalable platform combining operational CRO services with software and AI capabilities About Axiodis CRO Axiodis is a French clinical research organization specialized in biometrics, clinical data management and biostatistics. Through its proprietary Exagis platform and regulatory expertise, Axiodis supports biotech, pharmaceutical, medtech and academic sponsors in the execution of complex clinical studies Our Vision Oxurion’s ambition is to build a leading European clinical data ecosystem combining technology, regulatory expertise and operational excellence to accelerate the development of next-generation therapies.